ClearPoint Neuro, Inc. (CLPT) vs NeuroPace, Inc. (NPCE)
ClearPoint Neuro, Inc. and NeuroPace, Inc. are both Medical Devices companies. ClearPoint Neuro, Inc. and NeuroPace, Inc. are of similar size ($479.5M and $445.7M). ClearPoint Neuro, Inc. grew revenue faster over the last twelve months: 25.9% against 21.7%. NeuroPace, Inc. has the higher net margin (−18.6% vs −81.8%) and the higher return on invested capital (−44.6% vs −61.3%). Across the 18 metrics below, NeuroPace, Inc. leads on 14 and ClearPoint Neuro, Inc. on 4.
Valuation
Profitability
| Metric | CLPT | NPCE | Medical Devices median |
|---|---|---|---|
| Gross margin | 62.61% | 78.38% | 56.01% |
| Operating margin | (73.42%) | (13.33%) | (15.03%) |
| Net margin | (81.76%) | (18.58%) | (20.40%) |
| Free cash flow margin | (74.01%) | (11.29%) | (7.24%) |
| Return on equity | (226.52%) | (122.05%) | (15.32%) |
| Return on assets | (46.21%) | (18.82%) | (19.72%) |
| Return on invested capital | (61.31%) | (44.64%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack